Medical Condition News

RSS

Microgravity may suppress tumors, study reveals

In space, things don't always behave the way we expect them to. In the case of cancer, researchers have found that this is a good thing: some tumors seem to be much less aggressive in the microgravity environment of space compared to their behavior on Earth. This observation, reported in research published in February by the FASEB Journal, could help scientists understand the mechanism involved and develop drugs targeting tumors that don't respond to current treatments. This work is the latest in a large body of evidence on how space exploration benefits those of us on Earth.

4 Mar 2014

Study findings support the hypothesis of cognitive reserve in traumatic brain injury

Kessler Foundation researchers have found that higher educational attainment (a proxy of intellectual enrichment) attenuates the negative impact of traumatic brain injury (TBI) on cognitive status.

4 Mar 2014

3-D imaging of two different mouse models helps understand Apert Syndrome development

Three dimensional imaging of two different mouse models of Apert Syndrome shows that cranial deformation begins before birth and continues, worsening with time, according to a team of researchers who studied mice to better understand and treat the disorder in humans.

4 Mar 2014

Levels of bisphenol A in men's urine could be marker of prostate cancer

Findings by Cincinnati Cancer Center researchers show that levels of bisphenol A (BPA) in men's urine could be a marker of prostate cancer and that low levels of BPA exposure can cause cellular changes in both non-malignant and malignant prostate cells.

4 Mar 2014

LUNGevity Foundation awarded grant to develop educational materials on immuno-oncology

LUNGevity Foundation is honored to announce a grant of $250,000 from Bristol-Myers Squibb for the development of educational materials on immuno-oncology. Progress in understanding lung cancer and treatment approaches has accelerated dramatically in the past several years after many slow decades.

4 Mar 2014

Naurex's GLYX-13 receives FDA Fast Track designation

Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.

4 Mar 2014

Research: Microbes living in gut help drive development of intestinal tumors

It is not only genetics that predispose to bowel cancer; microbes living in the gut help drive the development of intestinal tumors, according to new research in mice published in the March issue of The Journal of Experimental Medicine.

4 Mar 2014

Acucela completes patient enrollment in Phase 2b/3 clinical trial of emixustat hydrochloride

Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).

4 Mar 2014

People with sleep apnea appear to be at increased risk of pneumonia

People with sleep apnea appear to be at higher risk of pneumonia than people without, according to a study published in CMAJ (Canadian Medical Association Journal).

4 Mar 2014

Researchers discover that carbohydrates serve as identifiers for cancer cells

Researchers at New York University and the University of Texas at Austin have discovered that carbohydrates serve as identifiers for cancer cells. Their findings, which appear in the journal Proceedings of the National Academy of Sciences, show how these molecules may serve as signals for cancer and explain what's going on inside these cells, pointing to new ways in which sugars function as a looking glass into the workings of their underlying structures.

4 Mar 2014

Biostatistics provides clues to understanding autism: an interview with Dr Knut M. Wittkowski, The Rockefeller University

The incidence of autism spectrum disorders has increased sharply since it was first described 60 years ago. Today, ASD affects more than 1% of all children in the U.S. and about half of them develop a life-long disability.

3 Mar 2014

New article explores risks associated with using herbal cannabis for rheumatic conditions

Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology, explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.

3 Mar 2014

Doctors offer ways to help protect kidneys

The kidneys, two very important organs located in your back, help to continuously clean out wastes and extra fluid from your body. One in 10 Americans develops kidney disease due to diabetes, high blood pressure or a family history of kidney failure.

3 Mar 2014

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.

3 Mar 2014

New molecule fluorogenic probe for rapid assessment of individual's risk for Parkinson's disease

A team of researchers from National University of Singapore (NUS) have created the first two-photon, small molecule fluorogenic probe that can serve as a useful tool for the rapid assessment of an individual's potential risk for Parkinson's disease.

3 Mar 2014

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Atopix Therapeutics Ltd ("Atopix"), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the results of a Phase IIb asthma study with their lead compound OC459 at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting , San Diego, California, USA on March 1st.

3 Mar 2014

AACR to showcase latest breakthroughs in cancer research

The American Association for Cancer Research (AACR) will showcase newsworthy research on clinical trials, epidemiology, immunology, epigenetics, laboratory science, and translational medicine at its Annual Meeting, April 5-9.

3 Mar 2014

Exercising during pregnancy prevents weight gain and illness

Excessive weight gain during pregnancy increases the risk of suffering illnesses such as hypertension and gestational diabetes, or of having a premature birth or a birth by Caesarean; furthermore, it also has negative effects on the newly-born and increases the risk of infants being overweight by 30%.

3 Mar 2014

Microencapsulated drug delivery may soon revolutionize cancer treatment

Invasive and systemic cancer treatment is a necessary evil for many people with the devastating diagnosis. These patients endure therapies with ravaging side effects, including nausea, immune suppression, hair loss and even organ failure, in hopes of eradicating cancerous tissues in the body.

3 Mar 2014

Maximizing imaging techniques to bridge the gap between diagnosis and treatment of cancer

Glioblastoma multiforme is the most common form of brain cancer and patients with this diagnosis have a life expectancy of less than two years. In spite of the fact that its diagnosis is very good, an appropriate treatment remains elusive.

From Bruker BioSpin Group 3 Mar 2014

Medical Condition News

Microgravity may suppress tumors, study reveals

Study findings support the hypothesis of cognitive reserve in traumatic brain injury

3-D imaging of two different mouse models helps understand Apert Syndrome development

Levels of bisphenol A in men's urine could be marker of prostate cancer

LUNGevity Foundation awarded grant to develop educational materials on immuno-oncology

Naurex's GLYX-13 receives FDA Fast Track designation

Research: Microbes living in gut help drive development of intestinal tumors

Acucela completes patient enrollment in Phase 2b/3 clinical trial of emixustat hydrochloride

People with sleep apnea appear to be at increased risk of pneumonia

Researchers discover that carbohydrates serve as identifiers for cancer cells

Biostatistics provides clues to understanding autism: an interview with Dr Knut M. Wittkowski, The Rockefeller University

New article explores risks associated with using herbal cannabis for rheumatic conditions

Doctors offer ways to help protect kidneys

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

New molecule fluorogenic probe for rapid assessment of individual's risk for Parkinson's disease

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

AACR to showcase latest breakthroughs in cancer research

Exercising during pregnancy prevents weight gain and illness

Microencapsulated drug delivery may soon revolutionize cancer treatment

Maximizing imaging techniques to bridge the gap between diagnosis and treatment of cancer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News